Publication
Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies
Flora Zagouri, Efstathios Kastritis, Athanasios Zomas, Evangelos Terpos, Eirini Katodritou, Argiris Symeonidis, Sosana Delimpasi, Anastasia Pouli, Theodoros P. Vassilakopoulos, Eurydiki Michalis, Stavroula Giannouli, Zafiris Kartasis, Anna Christoforidou, Kiriaki Kokoviadou, Eleftheria Hatzimichael, Dimitra Gika, Catherine Megalakaki, Maria Papaioannou, Marie-Christine Kyrtsonis, Kostas Konstantopoulos, Meletios A. Dimopoulos
European Journal Of Haematology, September 2017, Wiley
DOI: 10.1111/ejh.12923